Cargando…
Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358340/ https://www.ncbi.nlm.nih.gov/pubmed/32733476 http://dx.doi.org/10.3389/fimmu.2020.01435 |
_version_ | 1783558832160505856 |
---|---|
author | Sarcevic, Jelena Cavelti-Weder, Claudia Berger, Christoph T. Trendelenburg, Marten |
author_facet | Sarcevic, Jelena Cavelti-Weder, Claudia Berger, Christoph T. Trendelenburg, Marten |
author_sort | Sarcevic, Jelena |
collection | PubMed |
description | Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on the immune system are less well-understood. Here, we describe a 21-year old patient with hypercortisolism due to an ACTH producing thymic tumor. In this patient, we observed a decrease in some of the immunoglobulin classes, and in specific B and T cell populations that resembled effects caused by corticosteroid treatment. IgG levels were restored following treatment and normalization of the hypercortisolism. |
format | Online Article Text |
id | pubmed-7358340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73583402020-07-29 Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism Sarcevic, Jelena Cavelti-Weder, Claudia Berger, Christoph T. Trendelenburg, Marten Front Immunol Immunology Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on the immune system are less well-understood. Here, we describe a 21-year old patient with hypercortisolism due to an ACTH producing thymic tumor. In this patient, we observed a decrease in some of the immunoglobulin classes, and in specific B and T cell populations that resembled effects caused by corticosteroid treatment. IgG levels were restored following treatment and normalization of the hypercortisolism. Frontiers Media S.A. 2020-07-07 /pmc/articles/PMC7358340/ /pubmed/32733476 http://dx.doi.org/10.3389/fimmu.2020.01435 Text en Copyright © 2020 Sarcevic, Cavelti-Weder, Berger and Trendelenburg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Sarcevic, Jelena Cavelti-Weder, Claudia Berger, Christoph T. Trendelenburg, Marten Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title | Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title_full | Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title_fullStr | Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title_full_unstemmed | Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title_short | Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism |
title_sort | case report—secondary antibody deficiency due to endogenous hypercortisolism |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358340/ https://www.ncbi.nlm.nih.gov/pubmed/32733476 http://dx.doi.org/10.3389/fimmu.2020.01435 |
work_keys_str_mv | AT sarcevicjelena casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism AT caveltiwederclaudia casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism AT bergerchristopht casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism AT trendelenburgmarten casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism |